Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Short Interest

<< Previous

Bullboard Posts

Next >>

Post by homestandon Aug 09, 2023 8:24pm

270 Views

Post# 35580769

Short Interest

https://www.nasdaq.com/market-activity/stocks/oncy/short-interest

ONCY Short Interest

SETTLEMENT DATE	SHORT INTEREST	AVG. DAILY SHARE VOLUME	DAYS TO COVER
07/31/2023	1,932,279	851,894	2.268215
07/14/2023	1,377,481	1,204,693	1.143429
06/30/2023	1,233,458	2,715,517	1
06/15/2023	345,222	613,398	1
05/31/2023	325,595	475,750	1
05/15/2023	159,382	207,492	1
04/28/2023	68,199	137,834	1
04/14/2023	74,270	103,316	1
03/31/2023	115,784	152,848	1
03/15/2023	213,726	241,790	1
02/28/2023	185,667	152,569	1.216938
02/15/2023	177,513	281,705	1
01/31/2023	137,060	199,488	1
01/13/2023	94,040	180,296	1
12/30/2022	59,742	335,640	1
12/15/2022	132,217	675,194	1
11/30/2022	68,893	123,137	1
11/15/2022	111,156	330,762	1
10/31/2022	114,689	44,892	2.554776
10/14/2022	163,528	71,192	2.297
09/30/2022	161,101	45,639	3.529898
09/15/2022	199,335	64,462	3.092287
08/31/2022	259,028	103,277	2.50809
08/15/2022	236,623	134,302	1.761872